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Background: Medical laboratories play a central role in health care. Many laboratories are 
taking a more focused and stringent approach to quality system management. In Korea, 
laboratory standardization efforts undertaken by the Korean Laboratory Accreditation Pro-
gram (KLAP) and the Korean External Quality Assessment Scheme (KEQAS) may have fa-
cilitated an improvement in laboratory performance, but there are no fundamental studies 
demonstrating that laboratory standardization is effective. We analyzed the results of the 
KEQAS to identify significant differences between laboratories with or without KLAP and to 
determine the impact of laboratory standardization on the accuracy of diagnostic tests.
Methods: We analyzed KEQAS participant data on clinical chemistry tests such as albu-
min, ALT, AST, and glucose from 2010 to 2013. As a statistical parameter to assess per-
formance bias between laboratories, we compared 4-yr variance index score (VIS) be-
tween the two groups with or without KLAP.
Results: Compared with the group without KLAP, the group with KLAP exhibited signifi-
cantly lower geometric means of 4-yr VIS for all clinical chemistry tests (P <0.0001); this 
difference justified a high level of confidence in standardized services provided by accred-
ited laboratories. Confidence intervals for the mean of each test in the two groups (accred-
ited and non-accredited) did not overlap, suggesting that the means of the groups are sig-
nificantly different.
Conclusions: These results confirmed that practice standardization is strongly associated 
with the accuracy of test results. Our study emphasizes the necessity of establishing a sys-
tem for standardization of diagnostic testing.
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INTRODUCTION
Medical laboratories play a central role in health care. Labora-
tory data are an integral part of physicians’ decision-making 
processes; 70% of all critical medical decisions are based on 
laboratory test results [1]. The purpose of a laboratory is to pro-
vide physicians and other health care professionals with infor-
mation that enables them to: (1) detect a disease or predisposi-
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tion to a disease, (2) confirm or reject a diagnosis, (3) establish 
prognosis, (4) guide patient management, and (5) monitor the 
efficacy of therapy. To successfully achieve these goals, every 
laboratory should strive to achieve medical, scientific, and tech-
nical expertise, obtain resources such as personnel, laboratory 
equipment, supplies, and facilities, and, most importantly, have 
a management set-up that ensures quality laboratory services.
Many laboratories are adopting a more focused and stringent 
approach to quality system management. The International Or-
ganization for Standardization (ISO) is the first quality manage-
ment system for medical laboratories. It establishes guidelines 
that reflect the highest level of quality [2]. The ISO 15189 has 
been adopted by the College of American Pathologists (CAP) in 
an effort to improve patient care through quality laboratory prac-
tices [3]. Similarly, the CLSI has developed 12 Quality System 
Essentials based on ISO standards. These 12 essentials serve 
as a starting point in establishing a quality system that covers 
pre-testing, testing, and post-testing operations [3]. In the United 
States, laboratory activities are highly regulated by healthcare-
related legislation such as the Clinical Laboratory Improvement 
Amendments (CLIA) of 1988 [4]. Most clinical laboratories in 
the United States have received CLIA certification to perform 
testing on human samples, which indicates that they meet per-
sonnel, operational, safety, and quality standards based on test 
complexity.
In Korea, no national regulatory standards have been devel-
oped for clinical laboratories. The standardization of laboratory 
practice depends on a private sector entity, the Korean Labora-
tory Accreditation Program (KLAP), and the Korean External Qual-
ity Assessment Scheme (KEQAS) [5, 6]. The KLAP was devel-
oped by the Korean Society of Laboratory Medicine in 1999, 
and was reorganized as the Laboratory Medicine Foundation in 
2010 [6]. A laboratory that meets the requirements of laboratory 
accreditation schemes can receive KLAP certification, which ex-
presses confidence in the quality of services provided by that 
laboratory [6]. The KEQAS was set up in 1976, and is currently 
run by the Korean Association of External Quality Assessment 
Service. The main objectives of the KEQAS are to compare test 
results among participating laboratories nationwide by using the 
same test item. The number of participants in the KEQAS is grad-
ually increasing [5].
The standardization efforts undertaken by the KLAP and KEQAS 
may have facilitated an improvement in laboratory performance 
in Korea; however, there are no fundamental studies demon-
strating that laboratory standardization is useful. We analyzed 
the results of the KEQAS to identify significant differences be-
tween laboratories with and without KLAP, and to determine the 
impact of laboratory practice standardization on the accuracy of 
diagnostic testing.
METHODS
1. Study subjects and parameters 
Data from the KEQAS gathered between 2010 and 2013 by the 
clinical chemistry subcommittee of the Korean Association of 
External Quality Assessment Service were included in this study. 
A total of 19 test items related to clinical chemistry were analyzed: 
albumin, alkaline phosphatase, ALT, AST, blood urea nitrogen, 
chloride, creatinine, γ-glutamyl transferase, glucose, lactate de-
hydrogenase, phosphorus, potassium, sodium, total bilirubin, 
total calcium, total cholesterol, total protein, triglyceride, and uric 
acid [7]. As a statistical parameter to assess bias in performance 
between laboratories, we used the variance index score (VIS). 
The VIS ranges from 0 to 400, and it provides an overall com-
parison of test results for each test item. The value of the VIS is 
calculated as follows: VIS=[(Xlab–DV)/DV×100]/CCV×100; where 
Xlab is the result from the participating laboratory; DV is the des-
ignated value, which is the mean result from the participating 
laboratories using that method after excluding outliers more than 
two standard deviations from the mean; and CCV is the chosen 
coefficient of variation, taken from the National External Quality 
Assessment Scheme in the United Kingdom (1971) [8].
2.  Comparison of 4-yr VIS between laboratories with or 
without KLAP 
KEQAS participants, whose data on clinical chemistry tests were 
available, were categorized into two subgroups based on their 
KLAP status, and the VIS of each test item from 2010–2013 was 
compared. The number of laboratories participating in the KEQAS 
was 1,333 in 2013 [7]. Among the KEQAS participants with avail-
able data, the number of laboratories with or without KLAP, by 
year, was 233/767 (23% accredited; 77% non-accredited) in 
2010, 245/844 (22% accredited; 78% non-accredited) in 2011, 
258/908 (22% accredited; 78% non-accredited) in 2012, and 
265/1,008 (21% accredited; 79% non-accredited) in 2013.
3.  Comparison of 4-yr VIS between laboratories categorized 
by institution type
All participants in the KEQAS were categorized into four labora-
tory subgroups based on the institutional type; these subgroups 
were general hospitals with 100 or more beds, hospitals with 30–
99 beds, clinics with less than 30 beds, and entrusted labora-
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Table 1. Comparison of variance index scores between laboratories with or without KLAP from 2010 to 2013
Test item Year
Accredited laboratory Non-accredited laboratory
P ‡
N* VIS† (95% CI) N* VIS† (95% CI)
Albumin 2010 232 40.9 (38.7–43.2) 722 47.6 (45.7–49.6) <0.0001
2011 244 36.4 (34.3–38.7) 789 44.3 (42.7–46.0) <0.0001
2012 257 36.3 (34.3–38.5) 845 45.2 (43.5–46.8) <0.0001
2013 264 38.3 (36.3–40.4) 937 48.3 (46.7–50.0) <0.0001
ALP 2010 228 39.8 (36.5–43.3) 696 50.0 (47.0–53.2) <0.0001
2011 240 40.6 (37.4–44.1) 764 53.3 (50.5–56.2) <0.0001
2012 254 40.5 (37.2–44.1) 815 50.2 (47.5–53.1) <0.0001
2013 261 43.8 (40.1–47.8) 892 57.4 (54.4–60.6) <0.0001
ALT 2010 233 33.2 (31.2–35.4) 767 38.4 (36.7–40.2) 0.0002
2011 245 28.8 (27.0–30.8) 844 37.1 (35.6–38.7) <0.0001
2012 258 32.7 (30.8–34.7) 908 41.3 (39.8–42.8) <0.0001
2013 265 33.6 (31.5–35.9) 1,008 43.3 (41.8–44.9) <0.0001
AST 2010 233 30.1 (28.2–32.2) 766 37.1 (35.5–38.7) <0.0001
2011 245 27.3 (25.6–29.1) 845 33.1 (31.9–34.4) <0.0001
2012 257 27.8 (25.9–29.7) 908 36.0 (34.6–37.3) <0.0001
2013 264 28.1 (26.3–30.1) 1,007 36.5 (35.1–38.0) <0.0001
BUN 2010 233 47.0 (44.0–50.2) 735 63.9 (61.0–67.0) <0.0001
2011 245 41.8 (39.3–44.4) 806 63.3 (60.7–66.1) <0.0001
2012 257 41.8 (39.4–44.3) 859 62.5 (60.0–65.1) <0.0001
2013 264 42.4 (39.9–45.0) 959 68.4 (65.7–71.2) <0.0001
Chloride 2010 224 76.1 (71.5–81.0) 424 107.7 (102.4–113.3) <0.0001
2011 236 75.3 (71.9–78.8) 471 101.9 (97.5–106.4) <0.0001
2012 248 78.3 (74.6–82.2) 507 102.3 (97.9–106.9) <0.0001
2013 256 85.0 (81.0–89.2) 561 99.0 (94.9–103.3) <0.0001
Creatinine 2010 228 45.8 (42.8–48.9) 754 66.9 (64.1–69.9) <0.0001
2011 240 45.7 (43.1–48.3) 829 61.4 (58.9–64.1) <0.0001
2012 254 45.6 (43.2–48.2) 892 63.7 (61.1–66.3) <0.0001
2013 261 46.1 (43.6–48.8) 993 68.2 (65.6–70.8) <0.0001
γ-glutamyl transferase 2010 229 27.6 (25.6–29.6) 749 36.8 (35.1–38.5) <0.0001
2011 241 27.9 (26.0–30.0) 824 34.5 (33.1–36.0) <0.0001
2012 254 27.8 (26.0–29.8) 886 33.8 (32.4–35.3) <0.0001
2013 261 27.3 (25.6–29.2) 983 36.2 (34.8–37.6) <0.0001
Glucose 2010 229 23.4 (21.9–24.9) 744 35.9 (34.3–37.6) <0.0001
2011 241 23.4 (22.1–24.9) 820 34.2 (32.8–35.7) <0.0001
2012 254 24.3 (22.8–26.0) 839 33.8 (32.5–35.3) <0.0001
2013 261 22.5 (21.1–24.1) 981 34.8 (33.4–36.2) <0.0001
LDH 2010 226 16.0 (14.3–18.0) 520 22.8 (20.9–24.8) <0.0001
2011 238 13.9 (12.6–15.2) 540 20.2 (18.7–21.8) <0.0001
2012 250 14.3 (13.2–15.5) 562 20.3 (18.9–21.7) <0.0001
2013 256 17.2 (15.9–18.5) 604 23.5 (22.0–25.2) <0.0001
Phosphorus 2010 219 33.4 (31.1–35.9) 283 45.8 (42.5–49.4) <0.0001
2011 231 29.2 (27.3–31.2) 307 43.8 (40.7–47.2) <0.0001
2012 245 29.7 (27.7–31.9) 326 40.3 (37.3–43.4) <0.0001
2013 251 28.9 (27.0–30.9) 338 40.1 (37.2–43.2) <0.0001
(continued to the next page)
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tory agencies. During 2010–2013, the number of laboratories in 
general hospitals varied between 321 and 356; the number of 
laboratories in hospitals varied between 314 and 453; the num-
ber of laboratories in clinics varied between 272 and 351; and 
the number laboratories in entrusted laboratory agencies varied 
between 11 and 15. We analyzed the VIS difference in each test 
by institutional type. Furthermore, we analyzed the difference in 
VIS between laboratories in general hospitals based on their KLAP 
status to rule out confounding factors such as personnel, labo-
ratory equipment, supplies, and facilities. These factors are likely 
to affect the value of the VIS, because the hospital and clinic in-
stitutional types had a very small number of KLAP-accredited 
laboratories. Therefore, only data from the general hospital group, 
which had a sufficient number of laboratories with or without 
KLAP spanning, were included in further analysis.
Test item Year
Accredited laboratory Non-accredited laboratory
P ‡
N* VIS† (95% CI) N* VIS† (95% CI)
Potassium 2010 225 48.9 (45.8–52.3) 438 73.6 (69.6–77.8) <0.0001
2011 237 45.5 (42.7–48.6) 484 74.7 (71.1–78.5) <0.0001
2012 248 44.6 (42.2–47.2) 519 66.1 (63.0–69.3) <0.0001
2013 255 43.4 (40.5–46.5) 574 68.5 (65.3–71.8) <0.0001
Sodium 2010 225 61.1 (57.0–65.5) 437 83.6 (79.3–88.2) <0.0001
2011 237 61.5 (57.9–65.4) 484 87.7 (83.5–92.1) <0.0001
2012 249 59.6 (56.4–63.0) 519 88.4 (84.5–92.6) <0.0001
2013 256 56.4 (53.1–59.9) 574 84.1 (80.4–87.9) <0.0001
Total bilirubin 2010 228 25.7 (23.8–27.8) 720 36.9 (34.9–38.9) <0.0001
2011 240 28.1 (26.1–30.2) 790 37.1 (35.4–38.9) <0.0001
2012 254 26.9 (25.0–29.0) 845 33.7 (32.1–35.4) <0.0001
2013 261 26.5 (24.7–28.5) 942 36.1 (34.6–37.7) <0.0001
Total calcium 2010 220 53.9 (50.3–57.8) 321 77.8 (72.9–83.0) <0.0001
2011 233 52.7 (49.6–56.0) 348 79.5 (75.1–84.1) <0.0001
2012 246 52.8 (49.5–56.4) 362 76.2 (72.1–80.6) <0.0001
2013 251 49.8 (46.7–53.1) 383 73.2 (68.8–77.9) <0.0001
Total cholesterol 2010 233 28.3 (26.5–30.2) 754 37.4 (35.7–39.1) <0.0001
2011 245 26.7 (25.0–28.4) 829 35.4 (34.1–36.8) <0.0001
2012 257 26.7 (25.1–28.3) 820 34.7 (33.3–36.2) <0.0001
2013 264 26.8 (25.2–28.4) 993 37.5 (36.1–39.0) <0.0001
Total protein 2010 233 57.0 (53.2–60.9) 715 75.4 (71.8–79.2) <0.0001
2011 245 53.1 (50.5–55.9) 780 74.9 (71.9–78.1) <0.0001
2012 258 51.2 (48.4–54.2) 834 71.9 (69.0–74.9) <0.0001
2013 265 50.2 (47.4–53.1) 855 75.5 (72.4–78.8) <0.0001
Triglyceride 2010 229 32.0 (29.3–34.9) 738 45.1 (42.7–47.5) <0.0001
2011 241 35.4 (32.8–38.3) 811 48.0 (45.5–50.6) <0.0001
2012 246 33.1 (30.7–35.8) 645 45.6 (43.1–48.3) <0.0001
2013 261 30.3 (28.3–32.4) 975 45.5 (43.5–47.7) <0.0001
Uric acid 2010 228 32.5 (30.4–34.7) 649 44.1 (41.9–46.5) <0.0001
2011 239 30.2 (28.3–32.2) 701 42.2 (40.3–44.3) <0.0001
2012 254 28.3 (26.7–30.1) 740 41.0 (39.2–43.0) <0.0001
2013 261 28.2 (26.6–29.9) 805 44.1 (42.0–46.2) <0.0001
*Number of laboratories; †Geometric mean of VIS; ‡P value by Student’s t-test using the log-transformed values.
Abbreviations: BUN, blood urea nitrogen; CI, confidence interval; KLAP, Korean Laboratory Accreditation Program; LDH, lactate dehydrogenase; VIS, variance 
index score.
Table 1. Continued
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Fig. 1. Comparison of geometric means of the variance index score (VIS) for clinical chemistry tests between laboratories with or without 
KLAP in 2013. The 95% confidence intervals for the mean of each test in the two groups did not overlap. (A) VIS<50 and (B) VIS: 50–100. 
The graph shows the clinical chemistry tests on the X-axis and the geometric means of the VIS on the Y-axis. 
Abbreviations: BUN, blood urea nitrogen; KLAP, Korean Laboratory Accreditation Program; γ -GT, γ-glutamyl transferase; VIS, variance index score.
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4. Statistical analysis
VIS differences between laboratories with or without KLAP were 
compared by Student’s t-test. One-way ANOVA followed by Tukey’s 
multiple comparison test was used to evaluate the statistical sig-
nificance of the differences among the institutional types. Loga-
rithmic transformation of VIS was performed because of its right 
skewed distribution. The values of VIS were reported as the geo-
metric mean with 95% confidence intervals. P values were based 
on two-sided comparisons, and P values<0.05 were considered 
statistically significant.
RESULTS
1.  Differences in the VIS between laboratories with or 
without KLAP 
Statistical data on VIS, by test, are listed in Table 1. Most of the 
VIS data received scores of less than 100, except for a chloride 
test result from laboratories without KLAP (107.7 in 2010, 101.9 
in 2011, and 102.3 in 2012). Relative to the group of laborato-
ries without KLAP, the group of laboratories with KLAP exhibited 
significantly lower geometric means of 4-yr VIS in all tests (P < 
0.0001). Confidence intervals for the mean of each test item in 
the two groups (accredited and non-accredited) did not overlap; 
this gap suggested that the means of the two groups were sig-
nificantly different (Table 1). The geometric means of VIS in 2013 
are shown in Fig. 1.
2.  Differences in the VIS between laboratories categorized 
by institution type
Laboratories in general hospitals and entrusted laboratory agen-
cies exhibited significantly lower geometric means of 4-yr VIS for 
all test items compared with that of laboratories in hospitals and 
clinics (P <0.0001) (Table 2). The laboratories in general hospi-
tals were further classified into two subgroups based on their 
KLAP status; the numbers in the accredited and non-accredited 
groups were 205 (64%) and 116 (36%) in 2010, 212 (65%) 
and 116 (35%) in 2011, 219 (66%) and 113 (34%) in 2012, 
and 221 (62%) and 135 (38%) in 2013, respectively. Among 
the laboratories in general hospitals, the means of 4-yr VIS in 
laboratories with KLAP were significantly lower than those in lab-
oratories without KLAP for blood urea nitrogen, chloride, creati-
nine, glucose, lactate dehydrogenase, phosphorus, potassium, 
sodium, total calcium, total cholesterol, triglyceride, and uric acid 
(Table 3). 
DISCUSSION
The major finding of this study is that the 4-yr VIS was significantly 
different between laboratories with or without KLAP. The VIS scores 
in KLAP-accredited laboratories were significantly lower than those 
in laboratories without KLAP for all clinical chemistry tests; this 
difference justifies a high level of confidence in standardized ser-
vices provided by accredited laboratories. The present study is 
the first to demonstrate a strong impact of practice standardiza-
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Table 2. Comparison of variance index scores between laboratories categorized by institution type between 2010 and 2013
Test item Year
General hospital Hospital Clinic Entrusted laboratory
P‡
N* VIS† (95% CI) N* VIS† (95% CI) N* VIS† (95% CI) N* VIS† (95% CI)
Albumin 2010 313 43.0 (40.9–45.3) 312 46.3 (43.7–49.2) 253 48.2 (44.7–51.9) 11 36.4 (29.6–44.6) 0.0302
2011 320 37.5§,|| (35.5–39.6) 350 44.9§ (42.6–47.4) 282 44.5|| (41.6–47.6) 12 35.5 (26.4–47.7) <0.0001
2012 324 37.1§,|| (35.2–39.1) 394 46.5§,¶ (44.1–48.9) 302 45.1||,** (42.3–48.1) 13 30.6¶,** (22.2–45.1) <0.0001
2013 345 39.7§,|| (37.7–41.9) 447 49.9§ (47.5–52.5) 321 47.3|| (44.6–50.1) 15 41.9 (33.6–52.1) <0.0001
ALP 2010 312 41.3§ (38.1–44.9) 308 47.5 (43.5–51.9) 229 52.6§ (46.9–59.1) 11 43.9 (26.2–73.4) 0.0058
2011 319 43.1§,|| (40.0–46.5) 346 52.8§ (48.9–57.0) 259 53.5|| (48.5–59.1) 12 42.7 (28.8–63.4) 0.0007
2012 323 40.9§,|| (37.7–44.2) 390 52.1§ (48.2–56.3) 274 49.5|| (44.7–54.8) 13 47.5 (29.7–75.9) 0.0005
2013 340 46.6§ (43.0–50.5) 436 59.8§ (55.3–64.6) 289 52.7 (47.9–58.0) 15 51.2 (31.6–82.7) 0.0004
ALT 2010 321 34.3§ (32.3–36.4) 314 38.5 (36.0–41.3) 272 40.6§ (37.6–43.8) 11 31.8 (25.8–39.2) 0.0042
2011 328 31.8§,|| (30.0–33.8) 353 36.0§ (34.0–38.2) 309 38.3|| (35.5–41.4) 12 32.0 (23.7–43.1) 0.0010
2012 332 35.4§,|| (33.5–37.3) 397 40.0§ (38.0–42.2) 335 42.6||,¶ (40.0–45.3) 13 27.5¶ (21.6–35.0) <0.0001
2013 356 36.0§,|| (34.0–38.2) 453 42.9§ (40.7–45.2) 351 44.5|| (41.8–47.5) 15 38.1 (31.1–46.6) <0.0001
AST 2010 321 31.2§,|| (29.4–33.0) 314 36.9§ (34.5–39.4) 271 38.9|| (36.1–41.9) 11 27.4 (21.0–35.6) <0.0001
2011 328 28.2§,|| (26.6–29.9) 353 32.3§ (30.4–34.2) 309 35.3|| (33.2–37.5) 12 29.9 (21.9–40.8) <0.0001
2012 332 28.7§,|| (27.1–30.5) 397 35.7§ (33.8–37.7) 334 36.8|| (34.4–39.3) 13 24.9 (18.9–32.8) <0.0001
2013 355 29.6§,|| (27.8–31.6) 453 35.3§ (33.3–37.4) 350 37.8|| (35.3–40.5) 15 32.4 (24.6–42.8) <0.0001
BUN 2010 314 51.2§,|| (48.2–54.3) 313 63.1§ (59.0–67.5) 255 64.6|| (59.1–70.6) 11 43.7 (34.0–56.2) <0.0001
2011 321 46.4§,|| (43.8–49.1) 352 62.8§ (59.2–66.7) 286 63.7|| (58.7–69.0) 12 46.4 (32.7–65.9) <0.0001
2012 325 45.0§,|| (42.7–47.5) 395 63.3§,¶ (59.9–67.0) 303 64.5||,** (59.8–69.5) 13 38.5¶,** (28.3–52.4) <0.0001
2013 351 48.1§,|| (45.3–51.1) 448 69.0§,¶ (65.2–73.1) 323 69.1||,** (64.2–74.4) 15 39.2¶,** (29.9–51.5) <0.0001
Chloride 2010 306 84.4§ (79.8–89.3) 273 108.3§ (101.6–115.3) 45 98.0 (81.2–118.3) 10 83.0 (63.5–108.4) <0.0001
2011 313 80.4§,|| (77.0–84.0) 311 104.6§ (99.0–110.5) 53 96.0|| (83.3–110.5) 11 90.1 (71.5–113.6) <0.0001
2012 316 85.1§ (81.1–89.2) 341 103.9§ (98.4–109.7) 65 90.3 (79.3–102.8) 12 76.0 (59.2–97.5) <0.0001
2013 323 88.3§ (84.4–92.4) 386 98.1§ (93.0–103.4) 71 99.6 (89.6–110.6) 15 89.2 (68.5–116.2) 0.0213
Creatinine 2010 313 48.8§,|| (46.1–51.6) 314 67.0§,¶ (62.9–71.5) 271 69.2||,** (64.1–74.9) 11 38.2¶,** (23.1–63.0) <0.0001
2011 320 47.4§,|| (44.9–50.0) 353 61.4§ (57.8–65.3) 306 64.2|| (59.5–69.3) 12 44.8 (35.9–55.9) <0.0001
2012 324 48.6§,|| (46.0–51.3) 397 62.9§ (59.3–66.8) 333 66.9||,¶ (62.4–71.8) 13 41.9¶ (35.4–49.7) <0.0001
2013 350 51.0§,|| (48.1–54.0) 453 68.3§,¶ (64.8–72.0) 349 71.3||,** (66.7–76.1) 15 38.5¶,** (30.0–49.3) <0.0001
γ-glutamyl  
   transferase
2010 313 30.5§,|| (28.6–32.5) 311 36.5§ (34.0–39.2) 271 36.2|| (33.2–39.5) 11 24.8 (18.0–34.1) 0.0005
2011 320 28.2§,|| (26.5–30.1) 348 35.6§ (33.4–37.9) 307 34.4|| (31.9–37.1) 12 25.6 (20.6–31.9) <0.0001
2012 324 29.4§,|| (27.6–31.2) 391 33.8§,¶ (31.8–35.9) 332 34.2||,** (31.6–37.0) 13 19.6¶,** (14.5–26.3) 0.0002
2013 350 30.5§,||,¶ (28.7–32.4) 443 35.1§,** (33.2–37.1) 348 37.0||,†† (34.5–39.6) 15 19.1¶,**,†† (13.9–26.4) <0.0001
Glucose 2010 313 26.6§,|| (25.0–28.4) 314 36.2§ (33.9–38.7) 270 33.9|| (31.2–36.9) 11 28.2 (21.8–36.3) <0.0001
2011 320 25.4§,|| (24.0–26.9) 353 34.4§ (32.4–36.6) 306 34.5|| (32.1–37.2) 12 26.9 (22.0–32.9) <0.0001
2012 324 26.0§,|| (24.5–27.6) 397 34.1§,¶ (32.1–36.1) 330 34.6||,** (32.2–37.1) 13 21.2¶,** (15.6–28.9) <0.0001
2013 350 26.1§,|| (24.4–28.0) 452 35.5§ (33.5–37.6) 346 33.2|| (30.8–35.7) 15 23.6 (17.1–32.5) <0.0001
LDH 2010 307 17.2§ (15.5–19.1) 239 24.1§ (21.3–27.3) 148 20.2 (17.2–23.8) 11 21.7 (10.8–43.9) 0.0007
2011 312 15.0§ (13.7–16.4) 256 21.3§ (19.0–23.8) 157 18.3 (15.9–21.1) 12 16.8 (11.0–25.7) <0.0001
2012 315 15.2§,|| (14.1–16.4) 284 20.3§ (18.6–22.1) 159 20.0|| (17.3–23.2) 13 13.9 (8.0–24.3) <0.0001
2013 327 19.3§ (17.8–20.8) 308 23.3§ (21.2–25.6) 165 22.2 (19.5–25.4) 14 13.7 (9.7–19.3) 0.0032
Phosphorus 2010 287 35.8§ (33.6–38.3) 142 46.8§ (42.0–52.1) 53 45.0 (37.3–54.3) 10 41.2 (28.2–60.4) 0.0001
2011 293 32.1§,|| (30.1–34.3) 159 42.9§ (38.9–47.4) 64 45.6|| (37.8–54.9) 11 27.3 (19.7–37.8) <0.0001
2012 298 31.6§,|| (29.5–33.9) 182 39.0§ (35.3–43.2) 68 42.6|| (36.2–50.1) 12 27.5 (18.8–40.3) 0.0001
2013 303 31.0§,|| (29.1–33.1) 189 40.3§,¶ (36.5–44.4) 72 39.1||,** (32.7–46.6) 14 23.9¶,** (17.1–33.5) <0.0001
(continued to the next page)
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Test item Year
General hospital Hospital Clinic Entrusted laboratory
P‡
N* VIS† (95% CI) N* VIS† (95% CI) N* VIS† (95% CI) N* VIS† (95% CI)
Potassium 2010 306 52.9§,|| (49.8–56.1) 283 77.3§,¶ (72.2–82.9) 49 76.3|| (63.9–91.1) 11 48.2¶ (36.9–63.0) <0.0001
2011 313 49.9§,|| (46.9–53.0) 319 78.2§ (73.6–83.0) 57 73.9|| (63.4–86.0) 12 54.8 (44.7–67.2) <0.0001
2012 315 48.6§,|| (46.0–51.4) 349 68.2§,¶ (64.6–72.1) 69 60.2|| (51.5–70.4) 13 43.4¶ (33.9–55.7) <0.0001
2013 322 46.3§,|| (43.4–49.3) 395 71.2§ (67.4–75.3) 74 63.9|| (55.5–73.6) 15 49.1 (35.1–68.7) <0.0001
Sodium 2010 306 63.9§,|| (60.1–68.0) 283 85.1§ (79.9–90.8) 48 100.4|| (84.7–119.1) 11 67.8 (47.5–96.7) <0.0001
2011 313 65.3§,|| (61.6–69.2) 319 88.6§ (83.6–93.8) 57 92.6|| (79.4–108.0) 12 80.1 (57.4–111.8) <0.0001
2012 316 62.8§,|| (59.5–66.3) 349 91.4§ (86.6–96.4) 69 87.5|| (76.8–99.6) 13 69.4 (52.8–91.3) <0.0001
2013 323 59.8§,|| (56.6–63.2) 395 86.1§,¶ (81.7–90.8) 74 81.5||,** (71.9–92.4) 15 55.0¶,** (41.1–73.6) <0.0001
Total bilirubin 2010 312 26.6§,|| (24.9–28.5) 310 36.8§,¶ (33.8–40.0) 248 40.1||,** (36.4–44.3) 11 20.2¶,** (15.4–26.6) <0.0001
2011 319 28.7§,|| (26.9–30.7) 350 37.8§ (35.8–40.5) 278 38.0|| (34.8–41.4) 12 29.2 (22.1–38.6) <0.0001
2012 323 27.0§,|| (25.2–29.0) 394 33.9§ (31.7–36.2) 299 34.4|| (31.4–37.6) 13 24.2 (19.2–30.5) <0.0001
2013 348 28.3§,|| (26.4–30.4) 446 35.1§ (33.0–37.3) 319 37.7|| (35.0–40.7) 15 26.5 (19.2–36.7) <0.0001
Total calcium 2010 295 57.8§,|| (54.4–61.5) 164 81.9§ (74.9–89.5) 60 74.9|| (62.7–89.4) 10 65.2 (48.5–87.6) <0.0001
2011 302 57.6§,|| (54.4–60.9) 185 82.9§,¶ (76.9–89.2) 71 75.4|| (64.9–87.5) 11 54.6¶ (42.6–69.9) <0.0001
2012 305 57.6§,|| (54.3–60.9) 205 79.4§ (73.4–85.9) 74 67.6 (58.8–77.6) 12 46.5|| (31.5–68.5) <0.0001
2013 312 52.1§,|| (49.1–55.3) 217 77.5§ (71.3–84.2) 76 71.8|| (62.5–82.5) 14 54.8 (44.3–67.8) <0.0001
Total 
   cholesterol
2010 315 29.2§,|| (27.6–30.9) 314 37.7§ (35.2–40.3) 272 37.4|| (34.6–40.5) 11 26.5 (18.1–39.0) <0.0001
2011 322 28.4§,|| (26.9–30.0) 351 36.6§ (34.6–38.7) 308 33.8|| (31.5–36.3) 12 27.0 (19.4–37.6) <0.0001
2012 324 27.5§,|| (26.0–29.1) 389 36.0§ (34.0–38.1) 331 34.5|| (32.1–37.1) 13 29.8 (24.3–36.5) <0.0001
2013 352 30.1§,|| (28.3–31.9) 450 37.7§ (35.7–39.9) 349 36.1|| (33.8–38.6) 15 26.0 (20.5–32.9) <0.0001
Total protein 2010 314 59.1§,|| (55.6–62.8) 312 78.4§ (73.3–83.9) 248 73.8|| (67.0–81.2) 11 61.5 (48.6–77.7) <0.0001
2011 321 58.8§,|| (55.9–61.8) 350 74.3§ (70.1–78.7) 275 75.1|| (69.5–81.0) 12 52.9 (40.5–69.0) <0.0001
2012 325 55.2§,|| (52.4–58.1) 394 73.0§ (69.0–77.3) 293 70.3|| (65.3–75.8) 13 53.6 (39.3–73.0) <0.0001
2013 340 56.9§,|| (53.7–60.3) 433 77.4§ (73.1–82.0) 311 71.5|| (66.4–77.0) 15 53.2 (40.4–70.1) <0.0001
Triglyceride 2010 312 37.1§,|| (34.2–40.2) 304 45.0§ (41.3–49.0) 269 45.0|| (41.4–48.9) 11 35.8 (21.5–59.8) 0.0023
2011 318 39.8§,|| (36.8–43.0) 341 47.2§ (43.4–51.3) 305 48.1|| (44.4–52.2) 12 35.3 (19.4–64.2) 0.0029
2012 310 36.4§,|| (33.8–39.3) 301 45.0§ (41.3–49.1) 259 44.6|| (41.1–48.5) 11 34.0 (21.0–55.0) 0.0005
2013 349 35.3§,|| (32.8–38.0) 439 45.7§,¶ (42.6–49.0) 347 44.4||,** (41.4–47.5) 15 26.1¶,** (21.5–31.8) <0.0001
Uric acid 2010 311 34.4§,|| (32.4–36.6) 281 45.5§ (42.2–49.1) 207 43.5|| (39.3–48.2) 11 33.3 (25.7–43.3) <0.0001
2011 318 31.8§,|| (30.1–33.6) 315 43.0§ (40.2–46.0) 225 42.7|| (38.7–47.1) 11 35.5 (24.2–52.0) <0.0001
2012 322 30.1§,|| (28.4–31.8) 352 43.7§,¶ (41.0–46.6) 236 39.3|| (35.7–43.2) 13 26.3¶ (20.4–33.9) <0.0001
2013 346 33.0§,|| (31.0–35.2) 386 45.7§,¶ (42.8–48.8) 245 40.8||,** (37.2–44.7) 15 24.6¶,** (19.4–31.1) <0.0001
*Number of laboratories; †Geometric mean of the VIS; ‡P value represents overall differences across groups as determined by ANOVA using log-transformed 
values; §, ||, ¶, **, ††Matching letters indicate statistical significance based on Tukey’s multiple comparison.
Abbreviations: see Table 1.
Table 2. Continued
tion on the accuracy of test results. 
Implementation of laboratory standards is verified through the 
process of accreditation. In many countries, accreditation of medi-
cal laboratories has been established for several decades [9-12]. 
Accredited medical laboratories should have a well-functioning 
quality management system, demonstrate technical competence, 
and provide timely and customer-focused services that contrib-
ute to patient care. Our observation of a lower VIS in KLAP-ac-
credited laboratories suggests that the KLAP assesses laborato-
ries in accordance with the accepted standards. This finding 
provides external validation that KLAP-accredited laboratory ser-
vices are accurate, traceable, and reproducible. 
Clinical laboratories must provide high-quality services by pro-
ducing accurate, precise, relevant, and comprehensive data, 
which have a direct impact on the medical management of pa-
tients [1]. Enhancement of the quality of laboratory services in-
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Table 3. Comparison of variance index scores between laboratories in the general hospital group between 2010 and 2013
Test item Year
Accredited laboratory Non-accredited laboratory
P‡
N* VIS† (95% CI) N* VIS† (95% CI)
Albumin 2010 205 40.8 (38.5–43.4) 108 47.5 (43.5–52.0) 0.0045
2011 212 36.4 (34.1–38.9) 108 39.6 (36.0–43.6) 0.1534
2012 219 36.5 (34.3–38.9) 105 38.3 (34.9–42.1) 0.3865
2013 221 37.6 (35.4–39.9) 124 43.9 (39.8–48.6) 0.0080
ALP 2010 203 39.3 (36.0–43.0) 109 45.4 (38.5–53.6) 0.1310
2011 210 40.3 (37.0–44.0) 109 49.1 (42.5–56.6) 0.0209
2012 217 39.9 (36.5–43.6) 106 42.9 (36.5–50.4) 0.4376
2013 219 43.4 (39.6–47.5) 121 53.1 (45.5–61.9) 0.0262
ALT 2010 205 33.9 (31.7–36.3) 116 35.0 (31.2–39.2) 0.6480
2011 212 29.1 (27.2–31.3) 116 37.4 (33.8–41.4) <0.0001
2012 219 33.4 (31.3–35.6) 113 39.6 (36.0–43.5) 0.0028
2013 221 34.0 (31.6–36.5) 135 39.6 (35.8–43.9) 0.0130
AST 2010 205 30.0 (27.9–32.2) 116 33.4 (30.3–36.8) 0.0794
2011 212 27.3 (25.5–29.3) 116 29.8 (26.7–33.2) 0.1722
2012 219 27.7 (25.7–29.8) 113 30.8 (27.9–34.0) 0.0914
2013 221 28.0 (26.0–30.1) 134 32.6 (29.2–36.4) 0.0199
BUN 2010 205 46.9 (43.8–50.3) 109 60.2 (54.3–66.8) <0.0001
2011 212 41.2 (38.7–43.9) 109 58.4 (52.6–64.8) <0.0001
2012 219 42.2 (39.7–45.0) 106 51.4 (46.9–56.3) 0.0005
2013 221 42.3 (39.7–45.1) 130 59.7 (53.3–66.8) <0.0001
Chloride 2010 203 76.0 (71.2–81.1) 103 103.9 (94.2–114.5) <0.0001
2011 210 74.7 (71.2–78.5) 103 93.4 (86.3–101.2) <0.0001
2012 217 77.5 (73.6–81.7) 99 104.2 (95.5–113.7) <0.0001
2013 219 83.1 (79.0–87.4) 104 100.2 (91.7–109.5) 0.0004
Creatinine 2010 203 44.8 (41.9–47.9) 110 57.1 (51.8–62.9) <0.0001
2011 210 45.2 (42.4–48.1) 110 51.9 (46.8–57.5) 0.0257
2012 217 45.1 (42.5–47.9) 107 56.5 (50.6–63.1) 0.0005
2013 219 45.6 (43.0–48.3) 131 61.5 (54.8–69.0) <0.0001
γ-glutamyl transferase 2010 203 27.7 (25.6–29.9) 110 36.5 (32.8–40.6) <0.0001
2011 210 27.8 (25.7–30.0) 110 29.1 (26.0–32.6) 0.5024
2012 217 28.5 (26.5–30.6) 107 31.2 (27.9–34.8) 0.1758
2013 219 27.9 (26.0–29.9) 131 35.3 (31.6–39.4) 0.0004
Glucose 2010 203 23.2 (21.7–24.9) 110 34.3 (30.7–38.3) <0.0001
2011 210 23.2 (21.8–24.7) 110 30.3 (27.4–33.6) <0.0001
2012 217 23.8 (22.2–25.4) 107 31.3 (28.0–35.1) <0.0001
2013 219 22.1 (20.6–23.8) 131 34.5 (30.6–38.9) <0.0001
LDH 2010 201 15.2 (13.5–17.1) 106 21.7 (17.9–26.4) 0.0021
2011 208 13.2 (12.0–14.6) 104 19.2 (16.1–23.0) 0.0004
2012 214 14.0 (12.9–15.2) 101 18.1 (15.4–21.4) 0.0064
2013 216 17.1 (15.8–18.5) 111 24.3 (20.6–28.7) 0.0002
(continued to the next page)
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Test item Year
Accredited laboratory Non-accredited laboratory
P‡
N* VIS† (95% CI) N* VIS† (95% CI)
Phosphorus 2010 198 32.9 (30.6–35.4) 89 43.4 (38.0–49.4) 0.0001
2011 205 29.2 (27.2–31.4) 88 40.1 (35.1–45.8) <0.0001
2012 214 29.4 (27.4–31.7) 84 37.9 (32.6–44.1) 0.0033
2013 217 29.0 (27.0–31.2) 86 36.7 (32.1–42.0) 0.0011
Potassium 2010 203 48.4 (45.1–51.9) 103 63.0 (56.5–70.2) <0.0001
2011 210 44.4 (41.4–47.6) 103 63.1 (56.6–70.3) <0.0001
2012 216 44.0 (41.5–46.7) 99 60.4 (53.9–67.7) <0.0001
2013 218 41.9 (39.0–45.1) 104 56.8 (50.9–63.4) <0.0001
Sodium 2010 203 59.5 (55.3–64.0) 103 73.7 (66.0–82.3) 0.0011
2011 210 59.7 (56.0–63.6) 103 78.5 (70.0–88.0) <0.0001
2012 217 57.2 (54.0–60.6) 99 76.9 (68.9–85.9) <0.0001
2013 219 54.4 (51.1–58.0) 104 72.9 (65.9–80.7) <0.0001
Total bilirubin 2010 203 25.6 (23.6–27.8) 109 28.6 (25.2–32.4) 0.1378
2011 210 27.6 (25.5–29.9) 109 31.0 (27.7–34.7) 0.0926
2012 217 26.8 (24.7–29.1) 106 27.5 (24.3–31.2) 0.7206
2013 219 26.0 (24.0–28.2) 129 32.6 (28.7–37.2) 0.0036
Total calcium 2010 200 52.9 (49.2–57.0) 95 69.7 (62.7–77.5) <0.0001
2011 208 51.8 (48.5–55.3) 94 72.8 (66.0–80.3) <0.0001
2012 216 53.3 (49.8–57.1) 89 69.2 (62.9–76.1) <0.0001
2013 217 48.7 (45.7–52.1) 95 60.5 (53.6–68.4) 0.0024
Total cholesterol 2010 205 27.8 (25.9–29.7) 110 32.1 (28.9–35.6) 0.0188
2011 212 26.0 (24.3–27.9) 110 33.7 (30.8–36.8) <0.0001
2012 219 25.7 (24.1–27.5) 105 31.6 (28.4–35.3) 0.0007
2013 221 26.4 (24.8–28.0) 131 37.5 (33.3–42.1) <0.0001
Total protein 2010 205 57.1 (53.1–61.4) 109 62.9 (56.3–70.4) 0.1389
2011 212 53.4 (50.6–56.4) 109 70.9 (64.4–78.1) <0.0001
2012 219 50.9 (47.9–54.0) 106 65.1 (59.2–71.7) <0.0001
2013 221 50.5 (47.5–53.7) 119 71.0 (63.5–79.3) <0.0001
Triglyceride 2010 203 32.2 (29.3–35.3) 109 48.5 (42.0–55.9) <0.0001
2011 210 35.3 (32.5–38.3) 108 50.3 (43.1–58.7) <0.0001
2012 212 32.7 (30.0–35.5) 98 46.2 (39.8–53.6) <0.0001
2013 219 29.4 (27.3–31.7) 130 47.9 (41.7–54.9) <0.0001
Uric acid 2010 203 32.4 (30.2–34.7) 108 38.6 (34.4–43.2) 0.0100
2011 210 29.7 (27.7–31.7) 108 36.5 (33.3–40.0) 0.0005
2012 217 28.0 (26.2–29.9) 105 34.9 (31.6–38.5) 0.0003
2013 219 28.0 (26.3–29.9) 127 43.7 (38.8–49.3) <0.0001
*Number of laboratories; †Geometric mean of the VIS; ‡P value by Student’s t-test using log-transformed values.
Abbreviations: see Table 1. 
Table 3. Continued
volves laboratory quality management plans, including pre-ana-
lytic, analytic, and post-analytic plans, and standardization of 
activities and practices. A lack of standardization makes it im-
possible to guarantee the reliability or accuracy of laboratory test 
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results, which increases the error rate and endangers patient 
safety [13]. Laboratory standards critical to patient safety include 
proficiency testing, laboratory accreditation, continuing educa-
tion, safety goals, health information technology use, and elec-
tronic records. Therefore, accreditation bodies, consisting of in-
dependent entities as well as government authorities, should 
work to improve the quality of laboratory practices and patient 
safety.
We used the VIS statistical parameter, obtained from the KE-
QAS, to assess the standardized performance of different labo-
ratories. One could argue that the parameter accurately reflects 
laboratory standardization, because the KEQAS is run by a vol-
untary organization, and not government authorities. However, 
the KEQAS has great value in quality assessment, allowing a lab-
oratory to confirm that its results are consistent with those of other 
laboratories using the same or similar methods, and thus to con-
firm that it is correctly following the methods [14]. It is also im-
portant for maintaining long-term accuracy of analytical meth-
ods, and thus, it was chosen as a parameter to assess the effect 
of standardization.
In conclusion, our investigation of the KEQAS data confirmed 
that practice standardization is strongly associated with the accu-
racy of test results. Our analysis emphasizes the necessity of es-
tablishing a system for providing standardized diagnostic testing.
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